Journal of Clinical Pediatrics ›› 2020, Vol. 38 ›› Issue (9): 655-.doi: 10.3969/j.issn.1000-3606.2020.09.004

Previous Articles     Next Articles

Clinicopathological analysis of large B-cell lymphoma with IRF4 gene rearrangement in children

WU Chongjun, HUANG Hui, XIONG Ting, XU Zhongjin   

  1. Jiangxi Provincial Children's Hospital, The Affiliated Children's Hospital of Nanchang University, Nanchang 330000, Jiangxi, China
  • Published:2020-09-17

Abstract: Objective To explore the clinical and pathological features of large B-cell lymphoma with IRF4 gene rearrangement in children. Method The clinical data of large B cell lymphoma with IRF4 gene rearrangement in 3 children were retrospective analyzed. Results All the three cases were male and the age at onset was from 5 years and 4 months to 7 years and 10 months. The onset sites were tonsils, ileocecal, and cervical lymph nodes. The findings in histopathological morphology and immunohistochemistry of 3 children after surgery showed that the tumor cells were nodular or diffusely distributed. The tumor cells all expressed CD20, MUM1, BCL-6, and BCL-2, and they expressed CD10 in 2 cases. FISH was performed and showed fracture in IRF4 gene were negative in 2 cases and was positive in 1 case. All patients were diagnosed of large B-cell lymphoma with IRF4 gene rearrangement. All 3 cases were treated according to the CCCG-NHL-2016 regimen, 2 cases in group R2 and 1 case in group R3. Two patients had finished chemotherapy for more than one year, and no recurrence was found up to now. A child in R2 group with onset site of cervical lymph node was still under treatment and had achieved complete remission. Conclusion Large B-cell lymphoma with IRF4 gene rearrangement in children is rare. FISH detection of IRF4 gene is helpful for diagnosis and its treatment can be according to the CCCG-NHL-2016 regimen.

Key words:  large B-cell lymphoma with IRF4 gene rearrangement; pathology; treatment; child